BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 41 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $446,000 | -9.0% | 430,000 | 0.0% | 0.33% | -27.4% |
| Q2 2019 | $490,000 | -2.6% | 430,000 | -2.3% | 0.46% | +43.7% |
| Q1 2019 | $503,000 | -1.9% | 440,000 | -4.3% | 0.32% | -20.3% |
| Q4 2018 | $513,000 | -12.3% | 460,000 | -5.2% | 0.40% | +1.5% |
| Q3 2018 | $585,000 | -9.6% | 485,000 | -11.0% | 0.39% | +12.0% |
| Q2 2018 | $647,000 | +165.2% | 545,000 | +147.7% | 0.35% | +123.6% |
| Q1 2018 | $244,000 | +577.8% | 220,000 | +633.3% | 0.16% | +528.0% |
| Q4 2017 | $36,000 | – | 30,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonora Investment Management, LLC | 4,885,000 | $5,468,000 | 0.79% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 23,153,000 | $25,858,000 | 0.62% |
| RWC Asset Management LLP | 7,300,000 | $8,119,000 | 0.42% |
| IRON Financial LLC | 460,000 | $513,000 | 0.40% |
| Calamos Advisors LLC | 47,578,000 | $53,058,000 | 0.35% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 7,175,000 | $7,979,000 | 0.28% |
| Calamos Wealth Management LLC | 1,370,000 | $1,528,000 | 0.23% |
| SSI INVESTMENT MANAGEMENT LLC | 1,835,000 | $2,043,000 | 0.19% |
| OAKTREE CAPITAL MANAGEMENT LP | 13,120,000 | $14,628,000 | 0.13% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,221,000 | $3,613,000 | 0.13% |